Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178678
What this trial is testing

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
University of Saskatchewan 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04576117
What this trial is testing

Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

Who this might be right for
Recurrent Low Grade AstrocytomaRecurrent WHO Grade 2 GliomaRefractory Low Grade Astrocytoma+2 more
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Study completedNCT00362115
What this trial is testing

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Takeda 449
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06228391
What this trial is testing

Ketamine Treatment for PTSD and MDD in TBI

Who this might be right for
PTSD, Post Traumatic Stress DisorderMajor Depressive DisorderTraumatic Brain Injury
Minneapolis Veterans Affairs Medical Center 40
Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Not applicableStudy completedNCT05927376
What this trial is testing

Mediterranean-style Dietary Pattern (MDP), Mood and Anxiety

Who this might be right for
Depression, Anxiety
University of East Anglia 25
Testing effectiveness (Phase 2)Looking for participantsNCT06041789
What this trial is testing

Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

Who this might be right for
Osteoporosis
Duke University 45
Testing effectiveness (Phase 2)Study completedNCT03069144
What this trial is testing

Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPsoriasis Vulgaris
Haus Bioceuticals 28
Not applicableActive Not RecruitingNCT07517016
What this trial is testing

Real-Time Pose Recognition Technology for Improving Tennis Learning in Individuals With Intellectual Disabilities

Who this might be right for
Intellectual Disability, Mild to ModerateAdolescence
Burdur Mehmet Akif Ersoy University 30
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Not applicableStudy completedNCT02368743
What this trial is testing

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

Who this might be right for
Distal Ulcerative Colitis
Ferring Pharmaceuticals 117
Testing effectiveness (Phase 2)Ended earlyNCT01712074
What this trial is testing

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Who this might be right for
Alzheimer's Disease
Pfizer 186
Not applicableStudy completedNCT07154797
What this trial is testing

Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma

Who this might be right for
CataractOcular HypertensionGlaucoma
SpyGlass Pharma, Inc. 24
Not applicableStudy completedNCT01368835
What this trial is testing

Evaluation of the Ulthera™ System for Obtaining Lift and Tightening of the Cheek Tissue

Who this might be right for
Mild to Moderate Skin Laxity on CheekMild to Moderate Skin Laxity on Upper NeckMild to Moderate Subcutaneous Fat on Cheek+1 more
Ulthera, Inc 103
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01266525
What this trial is testing

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Dementia Alzheimer's Type
Sanofi 291
Early research (Phase 1)Study completedNCT01370317
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Who this might be right for
Asthma
Merck Sharp & Dohme LLC 27
Early research (Phase 1)Looking for participantsNCT07838220
What this trial is testing

IBI3016 in Japanese Participants

Who this might be right for
Hypertension
Innovent Biologics (Suzhou) Co. Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT04840459
What this trial is testing

Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Who this might be right for
Covid19
Sohail Rao 1,000
Next Page